CDT: Total pendapatan perusahaan conduitpharma.com

Conduit Pharmaceuticals develops therapies for renal pathologies, relying on investment attraction in the absence of revenue. The financial balance is maintained through the management of licensing deals with industry behemoths. The business model is based on the full outsourcing of drug development to external contractors. The company's sales trajectory in the GURU.Markets chart shows that 0.00 represents the current metric level.

Pendapatan perusahaan: Conduit Pharmaceuticals Inc. (CDT) kanggo 21.02.2024 - 13.11.2026

Rincian metrik komprehensif lan analitis Conduit Pharmaceuticals Inc. (CDT)

- rega pasar lan target rega analis:

Rega bursa Conduit Therapeutics|CDT - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar Conduit Pharmaceuticals Inc.|CDT - Nilai Perusahaan

- indikator nilai buku ekuitas:

Nilai Akuntansi saben Saham Conduit Pharmaceuticals|CDT - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku conduitpharma.com|CDT - Aset Agregat Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Utang marang Ekuitas Conduit Pharmaceuticals|CDT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal Conduit Pharmaceuticals Inc|CDT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Conduit Pharmaceuticals Inc.|CDT - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Conduit Pharmaceuticals|Rasio likuiditas perantara conduitpharma.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

CDT - Penghasilan resik|Penghasilan resik sing dikarepake Conduit Pharmaceuticals|CDT - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake conduitpharma.com|CDT - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Conduit Pharmaceuticals Inc.|CDT - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Conduit Pharmaceuticals|CDT - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan conduitpharma.com|CDT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Conduit Pharmaceuticals

- indikator volume dodolan lan pendapatan:

CDT - Pendapatan lan volume dodolan|Prakiraan volume dodolan Conduit Therapeutics|CDT - Multiplikator P/S|Multiplikator forward rega marang pendapatan Conduit Pharmaceuticals Inc.

Analisis umum perusahaan:CDT, Conduit Therapeutics

For Conduit Pharmaceuticals (CDT), which focuses on therapies for renal pathologies, the company's sales development vector reflects its current stage of zero commercial revenue. This indicator captures daily cash inflows from product sales, allowing investors to differentiate market noise from fundamental growth and assess the business valuation's dependence on clinical trial success and external financing.

Pesaing wigati

Total pendapatan perusahaan Travere Corp TVTX|Dodolan perusahaan ARDX (Ardelyx, Inc.)|PROK - Total pendapatan perusahaan|Pendapatan lan volume dodolan AKBA (Akebia Therapeutics, Inc.)|TVRD - Dodolan perusahaan|DMAC - Pendapatan perusahaan|Total pendapatan perusahaan Unicycive Therapeutics, Inc|Rockwell Medical, Inc. (RMTI) - Pendapatan perusahaan|Volume dodolan perusahaan CVKD|CALT (Calliditas Therapeutics, Inc.) - Pendapatan lan volume dodolan|Volume dodolan perusahaan RNLX (Renalytix PLC)|Dodolan perusahaan ZVSA (ZyVersa Therapeutics)